Direct-to-Consumer Marketing of Genetic Testing

Number 409

ABSTRACT: Marketing of genetic testing, although similar to direct-to-consumer advertising of prescription drugs, raises additional concerns and considerations. These include issues of limited knowle...

Professional Liability and Gynecology-Only Practice

Number 408

(Reaffirmed 2012, Replaces No. 288, October 2003)

ABSTRACT: Fellows of the American College of Obstetricians and Gynecologists may choose to limit the scope of their practices to gynecology. The College considers early pregnancy care (often up to 12...

Late-Preterm Infants

Number 404

(Reaffirmed 2011)

ABSTRACT: Late–preterm infants (defined as infants born between 34 0/7 weeks and 36 6/7 weeks of gestation) often are mistakenly believed to be as physiologically and metabolically mature as term inf...

End-of-Life Decision Making

Number 403

ABSTRACT: The purpose of this Committee Opinion is to discuss issues related to end–of–life care, including terms and definitions, ethical principles, legal constructs, physician–patient communicatio...

Surrogate Motherhood

Number 397

ABSTRACT: Ethical responsibilities are described for obstetrician–gynecologists who choose to participate in surrogacy arrangements by 1) advising couples who are considering surrogacy, 2) counseling...

Umbilical Cord Blood Banking

Number 399

(Reaffirmed 2012, Replaces No. 183, April 1997)

ABSTRACT: Two types of banks have emerged for the collection and storage of umbilical cord blood—public banks and private banks. Public banks promote allogenic (related or unrelated) donation, analog...

Intraperitoneal Chemotherapy for Ovarian Cancer

Number 396

(Reaffirmed 2010 )

ABSTRACT: Postoperative intravenous (IV) chemotherapy for advanced stage ovarian cancer has been the standard treatment. Recent studies have found significant survival advantages with the use of adju...

Surgery and Patient Choice

Number 395

ABSTRACT: Acknowledgment of the importance of patient autonomy and increased patient access to information has prompted more patient–generated requests for surgical interventions not necessarily reco...

Ethical Decision Making in Obstetrics and Gynecology

Number 390

(Reaffirmed 2010)

ABSTRACT: Physicians vary widely in their familiarity with ethical theories and methods and their sensitivity toward ethical issues. It is important for physicians to improve their skills in addressi...

Human Immunodeficiency Virus

Number 389

ABSTRACT: Because human immunodeficiency virus (HIV) infection often is detected through prenatal and sexually transmitted disease testing, an obstetrician–gynecologist may be the first health profes...

Supracervical Hysterectomy

Number 388

(Reaffirmed 2013)

ABSTRACT: Women with known or suspected gynecologic cancer, current or recent cervical dysplasia, or endometrial hyperplasia are not candidates for a supracervical procedure. Patients electing suprac...

The Limits of Conscientious Refusal in Reproductive Medicine

Number 385

(Reaffirmed 2010)

ABSTRACT: Health care providers occasionally may find that providing indicated, even standard, care would present for them a personal moral problem—a conflict of conscience—particularly in the field ...

Fetal Monitoring Prior to Scheduled Cesarean Delivery

Number 382

(Reaffirmed 2010)

ABSTRACT: There are insufficient data to determine the value of fetal monitoring prior to scheduled cesarean delivery in patients without risk factors.   With the increasing rate of schedule...

Subclinical Hypothyroidism in Pregnancy

Number 381

(Reaffirmed 2012)

ABSTRACT: Subclinical hypothyroidism is diagnosed in asymptomatic women when the thyroid-stimulating hormone level is elevated and the free thyroxine level is within the reference range. Thyroid horm...

Management of Delivery of a Newborn With Meconium-Stained Amniotic Fluid

Number 379

(Reaffirmed 2010)

ABSTRACT: In accordance with the new guidelines from the American Academy of Pediatrics and the American Heart Association, all infants with meconium-stained amniotic fluid should no longer routinely...

Vaginal "Rejuvenation" and Cosmetic Vaginal Procedures

Number 378

ABSTRACT: So-called "vaginal rejuvenation," "designer vaginoplasty," "revirgination," and "G-spot amplification" are vaginal surgical procedures being offered by some practitioners. These procedures ...

Research Involving Women

Number 377

ABSTRACT: All women should be presumed to be eligible for participation in clinical studies. The potential for pregnancy should not automatically exclude a woman from participating in a clinical stud...

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2012)

ABSTRACT: Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor. The American College of Obstetricians and Gynecologists finds data are insufficient to recommend...

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2010)

ABSTRACT:The U.S. Food and Drug Administration considers generic and brand name oral contraceptive (OC) products clinically equivalent and interchangeable. The American College of Obstetricians and G...

Expert Testimony

Number 374

(Reaffirmed 2010)

ABSTRACT: It is the duty of obstetricians and gynecologists who testify as expert witnesses on behalf of defendants, the government, or plaintiffs to do so solely in accordance with their judgment on...